Mavrilimumab
Product Specifications
CAS Number
1085337-57-0
Target
C-Fms, CSF-1R, Virus Protease
Related Pathways
Tyrosine Kinase/Adaptors, Microbiology/Virology
Purity
>95%
Bioactivity
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling. GM-CSF may contribute to an overactive inflammatory response linked to respiratory failure and death and could be used to study rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog